ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,093Hybrid

Neuropeptides

Acronym:npep
•
Abbreviation (ISO):NEUROPEPTIDES
•
Identifier (ISSN):0143-4179(Print)/1532-2785(Online)
•
Publisher:Churchill Livingstone
Clarivate IF (2026)
2.7– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neuropeptides

WoS Q3
12452.9220182.4120192.4120203.2920213.1520222.920232.520242.720252.72026
Annual Impact Factor Metric
Current (2026):2.7
Scopus SJR & RankScopus Q2
0.786
#7,093

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
83

83 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
55articles/year
20% Gold OA•90.38% Original Research

Aims & Scope

The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems. The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.

Topics Covered (Recognized by AI)
Biology92%Medicine91.2%Internal medicine89.4%Chemistry89.2%Biochemistry86.5%Genetics85.5%Receptor77%Endocrinology70.7%Psychology60.4%Neuroscience54.4%Neuropeptide43.6%Psychiatry23.9%Physics23.8%Pharmacology22.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank120/198
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q3
Rank208/330
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank118/198
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q3
Rank220/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.7
Articles / Year45
Total Citations11
2025
IF2.7
Articles / Year53
Total Citations164
2024
IF2.5
Articles / Year60
Total Citations312
2023
IF2.9
Articles / Year50
Total Citations416
2022
IF3.152
Articles / Year58
Total Citations540

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,093Scopus Q2SCImago Profile
Scopus Coverage:1980-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience
Scopus Citation Rank (SJR)Q2
0.786

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.20

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,131 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations454
3-Year Documents151
Citable Documents150

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
NeurologyQ2
Cellular and Molecular NeuroscienceQ3
Endocrine and Autonomic SystemsQ3
EndocrinologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuropeptides (acronym: npep, abbr: NEUROPEPTIDES, ISSN: 0143-4179) is a peer-reviewed international scholarly journal in the field of Medicine, published by Churchill Livingstone in Scotland since 1980. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.786 (Q2), an H-index of 83.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 55 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,131 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Churchill Livingstone
Publication Language
English
Frequency
Bimonthly
Founding Year
1980
Indexing & Databases
SCIEScopusPubMed
Editorial Address
CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f60de98d-c293-4b8b-b160-40c267a99c94
Database Updated: 2026-10-16